A cascade targeting strategy based on modified bacterial vesicles for enhancing cancer immunotherapy

BACKGROUND: As an efficient tumor immunotherapy, PD-1 antibody has been gradually used in clinical tumor treatment, but the low response rate and excessive immune response limit its extensive application. RESULTS: Herein, a therapeutic regime for the reinvigoration and activation of the tumor immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Yuewen, Ma, Yuying, Pang, Bo, Zhang, Jinnan, Li, Ying, Rui, Yalan, Xu, Tian, Zhao, Yu, Qian, Zhiyu, Gu, Yueqing, Li, Siwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686283/
https://www.ncbi.nlm.nih.gov/pubmed/34930285
http://dx.doi.org/10.1186/s12951-021-01193-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686283/
https://www.ncbi.nlm.nih.gov/pubmed/34930285
http://dx.doi.org/10.1186/s12951-021-01193-9

Ejemplares similares